Ypsomed reports positive outcomes from a randomized trial of its closed-loop insulin delivery technology during type 1 ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of ...

The Food and Drug Administration (FDA) has cleared the Eversense 365 continuous glucose monitoring (CGM) system for patients ...

A new study from researchers at the BU Chobanian & Avedisian School of Mediicne have that found that non-diabetic individuals using continuous glucose monitoring sensors  spend a much larger period of ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) on September 13 and set a price target of ...

Antidiabetics Market is estimated to reach US$ 223 Billion, displaying a CAGR of 9.6% during the assessment period from 2022- ...

today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by astronauts in space as part of the Polaris Dawn mission, which launched this morning and aims to better ...

Dexcom announced today that its G6 continuous glucose monitor (CGM) is being worn by astronauts as part of the Polaris Dawn ...

(Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by ...

Sept 5 (Reuters) - Abbott (ABT.N), opens new tab has launched its over-the-counter continuous glucose monitoring system in the ... will compete with a rival from DexCom (DXCM.O), opens new tab ...

Diabetes is a chronic, life-threatening disease for which there is no known cure. DexCom’s CGM system is superior to traditional fi nger-stick tests because it provides users with continuous ...